S
Shu Yang
Researcher at Jinan University
Publications - 14
Citations - 137
Shu Yang is an academic researcher from Jinan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 7 publications receiving 48 citations. Previous affiliations of Shu Yang include Southern University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE-/- mice.
Chuanrui Ma,Ronglin Xia,Shu Yang,Lipei Liu,Jing Zhang,Ke Feng,Yuna Shang,Jingtian Qu,Lingwei Li,Ning Chen,Shixin Xu,Wenwen Zhang,Jingyuan Mao,Jihong Han,Jihong Han,Yuanli Chen,Xiaoxiao Yang,Yajun Duan,Guanwei Fan +18 more
TL;DR: It is demonstrated that formononetin can substantially attenuate the development of atherosclerosis via regulation of interplay between KLF4 and SRA, which suggests the formonetin might be a novel therapeutic approach for inhibition of Atherosclerosis.
Journal ArticleDOI
Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
Shu Yang,Chuanrui Ma,Han Wu,Hao Zhang,Fengyi Yuan,Guangyan Yang,Qi Yang,Lijing Jia,Zhen Liang,Lin Kang +9 more
TL;DR: TEC treatment restored diabetes-induced glucose and lipid metabolic disorder; and improved the deterioration of renal function, particularly the renal endothelium function in db/db mice, suggesting that TEC have a potently effect for retarding type 2 diabetes-associated DN.
Journal ArticleDOI
Astragalus Flavone Ameliorates Atherosclerosis and Hepatic Steatosis Via Inhibiting Lipid-Disorder and Inflammation in apoE -/- Mice
Chuanrui Ma,Jing Zhang,Shu Yang,Yunqing Hua,Jing Su,Yuna Shang,Zhongyan Wang,Ke Feng,Jian Zhang,Xiaoxiao Yang,Hao Zhang,Jingyuan Mao,Guanwei Fan +12 more
TL;DR: TFA reduced atherosclerotic lesion size and enhanced plaque stability, which might be attributed to improved lipid disorder, reduced inflammation and decreased monocyte adhesion, suggesting that TFA might be a novel therapeutic approach for inhibition of atherosclerosis and hepatic steatosis.
Journal ArticleDOI
Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARγ.
Jiaqing Xiang,Guangyan Yang,Chuanrui Ma,Lingling Wei,Han Wu,Han Wu,Wei Zhang,Xiuhua Tao,Lingyun Jiang,Zhen Liang,Lin Kang,Shu Yang +11 more
TL;DR: Tectorigenin (TEC) alleviates intrahepatic cholestasis in mice by activating peroxisome proliferator-activated receptor-γ (PPARγ).
Journal ArticleDOI
miR-378 and its host gene Ppargc1β exhibit independent expression in mouse skeletal muscle.
Lin Kang,Chunmiao Han,Guangyan Yang,Hu Li,Tingting Li,Shu Yang,Na Liang,Ran Zhong,Lijing Jia,Dahai Zhu,Yong Zhang +10 more
TL;DR: The findings identify a regulatory model of miR-378 expression, thereby helping to understand its physiological function in skeletal muscle, and identify some intronic miRNAs that are processed from primary host gene transcripts and share the promoter of their host.